Hoth Therapeutics Q1 EPS $(0.17) Up From $(0.27) YoY

Benzinga Newsdesk www.benzinga.com Negative 48.5%

Neg 48.5% Neu 0% Pos 0%

Hoth Therapeutics (NASDAQ:HOTH) reported quarterly losses of $(0.17) per share. This is a 37.04 percent increase over losses of $(0.27) per share from the same period last year.